Literature DB >> 22951896

Expeditious and less traumatic explantation of a heartware LVAD after myocardial recovery.

Martin Schweiger1, Evgenij Potapov, Juliane Vierecke, Alexander Stepanenko, Roland Hetzer, Thomas Krabatsch.   

Abstract

After 169 days on left ventricular assist device (LVAD) support, a 62-year-old male patient suffering from idiopathic dilatative cardiomyopathy showed signs of left ventricular recovery. Off-pump trials were done, and our explantation criteria were met. The LVAD removal procedure was performed after 338 days on the device, using a left lateral thoracotomy in the sixth intercostal space. First, the outflow graft was transected and the distal end was sewed. Then, the pump was replaced by an individually manufactured titanium plug. Finally, the driveline was cut so that the device could be completely withdrawn. The rest of the driveline was accessed through a small abdominal incision and explanted through the percutaneous exit site.

Entities:  

Mesh:

Year:  2012        PMID: 22951896     DOI: 10.1097/MAT.0b013e3182640dce

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  3 in total

1.  Impella 5.0® as bridge-to-recovery short-term mechanical circulatory support after LVAD explantation.

Authors:  Anja Osswald; Bastian Schmack; Ranny Goldwasser; Michael M Kreusser; Philip W Raake; Matthias Karck; Arjang Ruhparwar
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 2.  Bridge to removal: a paradigm shift for left ventricular assist device therapy.

Authors:  Craig H Selzman; Jesse L Madden; Aaron H Healy; Stephen H McKellar; Antigone Koliopoulou; Josef Stehlik; Stavros G Drakos
Journal:  Ann Thorac Surg       Date:  2014-11-14       Impact factor: 4.330

3.  Successful bridge to recovery using two-stage HeartWare LVAD explantation approach after embolic stroke.

Authors:  Anton Sabashnikov; Benjamin A Högerle; Prashant N Mohite; Aron-Frederik Popov; Diana García Sáez; Javid Fatullayev; Mohamed Amrani; Thorsten Wahlers; André R Simon; Toufan Bahrami
Journal:  J Cardiothorac Surg       Date:  2013-12-30       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.